tradingkey.logo

Evotec SE

EVO
View Detailed Chart

3.720USD

+0.030+0.81%
Close 07/22, 16:00ETQuotes delayed by 15 min
1.32BMarket Cap
LossP/E TTM

Evotec SE

3.720

+0.030+0.81%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.81%

5 Days

-9.71%

1 Month

-1.06%

6 Months

-9.93%

Year to Date

-10.58%

1 Year

-20.85%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts
HOLD
Current Rating
6.000
Target Price
62.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

550
Total
5
Median
6
Average
Company name
Ratings
Analysts
Evotec SE
EVO
3
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
110

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(2)
Buy(0)
Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.098
Neutral
RSI(14)
36.404
Neutral
STOCH(KDJ)(9,3,3)
23.530
Sell
ATR(14)
0.146
High Vlolatility
CCI(14)
-210.890
Oversold
Williams %R
88.889
Oversold
TRIX(12,20)
-0.005
Sell
StochRSI(14)
6.503
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
4.026
Sell
MA10
4.084
Sell
MA20
4.141
Sell
MA50
4.109
Sell
MA100
3.886
Sell
MA200
4.077
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Ticker SymbolEVO
CompanyEvotec SE
CEODr. Christian Wojczewski
Websitehttps://www.evotec.com/
KeyAI